Two Hot Stocks Comparison: Clovis Oncology, Inc. (NASDAQ:CLVS), Smith (A.O.) Corporation (NYSE:AOS)

Clovis Oncology, Inc. (NASDAQ:CLVS)

Clovis Oncology, Inc. (NASDAQ:CLVS) closed at $25.32 on the last trading session with an decrease of -0.24%, whereas, it previously closed at $25.38. The company has a market capitalization of $1.34 Billion. The company traded shares of 1.77 Million on the trading day while its three month average volume stands at 2.54 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Clovis Oncology, Inc. (NASDAQ:CLVS) produced diluted EPS of -2.97. The EPS estimate for next year as estimated by analysts is at -6.23 while EPS for next quarter is estimated at -1.73. Earnings per Share growth for this year is reported at 56.9, while the analysts estimated the EPS growth for next year at -6.23% and Earnings growth for next 5 years stands at 29.4% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -5.7%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Clovis Oncology, Inc. (NASDAQ:CLVS) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Clovis Oncology, Inc. (NASDAQ:CLVS) stands at 16.3 and Price to Book or P/B for the most recent quarter stands at 5.7. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Clovis Oncology, Inc. (NASDAQ:CLVS) are reported at 8.5 and 9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Clovis Oncology, Inc. (NASDAQ:CLVS) stands at -39.2, -105.1 and -27.3 respectively

The trailing twelve month Revenue of Clovis Oncology, Inc. (NASDAQ:CLVS) is reported at 82.1 Million with income of -158400000. The outstanding shares of Clovis Oncology, Inc. (NASDAQ:CLVS) are 52.84 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is increased 5.69 in the last six months. The insider ownership for the shares of Clovis Oncology, Inc. (NASDAQ:CLVS) is ticked at 0.5%, the figure is plummeted -2.41% in the last six months.

Some other important financial aspects to be discussed here for Clovis Oncology, Inc. (NASDAQ:CLVS) is the Mean Target Price estimated by the analysts which stands at 28.1. The 52 week high of Clovis Oncology, Inc. (NASDAQ:CLVS) is placed at 65.24 and 52 week low is standing at 11.50.

Performance wise the shares of Clovis Oncology, Inc. (NASDAQ:CLVS) fell down -1.67% for the week, it also rise 6.34% for the monthly performance, while for the quarter it went down 64.95%. The shares decrease -27.76% for the half year and flew up for the Year-To-Date performance. The shares of Clovis Oncology, Inc. (NASDAQ:CLVS) shrinked -52.06% for the yearly performance.

Smith (A.O.) Corporation (NYSE:AOS)

Smith (A.O.) Corporation (NYSE:AOS) closed at $49.26 on the last trading session with an decrease of -0.1%, whereas, it previously closed at $49.31. The company has a market capitalization of $8.38 Billion. The company traded shares of 1.21 Million on the trading day while its three month average volume stands at 1.89 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Smith (A.O.) Corporation (NYSE:AOS) produced diluted EPS of 2.58. The EPS estimate for next year as estimated by analysts is at 2.97 while EPS for next quarter is estimated at 0.57. Earnings per Share growth for this year is reported at 17.3, while the analysts estimated the EPS growth for next year at 2.97% and Earnings growth for next 5 years stands at 9.35% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 19.9%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Smith (A.O.) Corporation (NYSE:AOS) is at 19.09 while the forward p/e is at 16.57. The P/S or Price to Sales ratio of Smith (A.O.) Corporation (NYSE:AOS) stands at 2.63 and Price to Book or P/B for the most recent quarter stands at 4.78. The Price to Free Cash Flow ratio or P/FCF is reported at 38.28. The quick ratio and the current ratio of Smith (A.O.) Corporation (NYSE:AOS) are reported at 1.7 and 2.2 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Smith (A.O.) Corporation (NYSE:AOS) stands at 10.6, 19.3 and 18.4 respectively

The trailing twelve month Revenue of Smith (A.O.) Corporation (NYSE:AOS) is reported at 3.19 Billion with income of 444.2 Million. The outstanding shares of Smith (A.O.) Corporation (NYSE:AOS) are 170.12 Million. The institutional Ownership of the shares of 99.3 stands at 0.80%, this figure is decreased -0.69 in the last six months. The insider ownership for the shares of Smith (A.O.) Corporation (NYSE:AOS) is ticked at 0.1%, the figure is plummeted -22.02% in the last six months.

Some other important financial aspects to be discussed here for Smith (A.O.) Corporation (NYSE:AOS) is the Mean Target Price estimated by the analysts which stands at 55.13. The 52 week high of Smith (A.O.) Corporation (NYSE:AOS) is placed at 66.89 and 52 week low is standing at 40.34.

Performance wise the shares of Smith (A.O.) Corporation (NYSE:AOS) rose up 2.26% for the week, it also rise 5.59% for the monthly performance, while for the quarter it went down 3.62%. The shares decrease -15.78% for the half year and flew up for the Year-To-Date performance. The shares of Smith (A.O.) Corporation (NYSE:AOS) shrinked -21.46% for the yearly performance.